It is well demonstrated that individuals with DS display elevated IFN signaling across multiple immune and non-immune cell types (Sullivan et al., 2016; Waugh et al., 2019; Araya et al., 2019; Powers et al., 2019). This evidence concerns the gene IFNA1 and Dravet syndrome.